431 related articles for article (PubMed ID: 16048923)
1. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.
Rouse MS; Rotger M; Piper KE; Steckelberg JM; Scholz M; Andrews J; Patel R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3187-91. PubMed ID: 16048923
[TBL] [Abstract][Full Text] [Related]
2. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
3. Agents for the decolonization of methicillin-resistant Staphylococcus aureus.
McConeghy KW; Mikolich DJ; LaPlante KL
Pharmacotherapy; 2009 Mar; 29(3):263-80. PubMed ID: 19249946
[TBL] [Abstract][Full Text] [Related]
4. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
5. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization.
Mehta MS; Hacek DM; Kufner BA; Price C; Peterson LR
Surg Infect (Larchmt); 2013 Feb; 14(1):69-72. PubMed ID: 23448592
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus.
Harbarth S; Liassine N; Dharan S; Herrault P; Auckenthaler R; Pittet D
Clin Infect Dis; 2000 Dec; 31(6):1380-5. PubMed ID: 11096006
[TBL] [Abstract][Full Text] [Related]
7. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
Jones JC; Rogers TJ; Brookmeyer P; Dunne WM; Storch GA; Coopersmith CM; Fraser VJ; Warren DK
Clin Infect Dis; 2007 Sep; 45(5):541-7. PubMed ID: 17682986
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic nasal carriage of mupirocin-resistant, methicillin-resistant Staphylococcus aureus (MRSA) in a pet dog associated with MRSA infection in household contacts.
Manian FA
Clin Infect Dis; 2003 Jan; 36(2):e26-8. PubMed ID: 12522764
[TBL] [Abstract][Full Text] [Related]
9. MRSA decolonization of cotton rat nares by a combination treatment comprising lysostaphin and the antimicrobial peptide ranalexin.
Desbois AP; Sattar A; Graham S; Warn PA; Coote PJ
J Antimicrob Chemother; 2013 Nov; 68(11):2569-75. PubMed ID: 23800902
[TBL] [Abstract][Full Text] [Related]
10. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis.
Hurdle JG; O'Neill AJ; Mody L; Chopra I; Bradley SF
J Antimicrob Chemother; 2005 Dec; 56(6):1166-8. PubMed ID: 16275681
[TBL] [Abstract][Full Text] [Related]
11. Emergence and spread of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from a community hospital in Japan.
Watanabe H; Masaki H; Asoh N; Watanabe K; Oishi K; Furumoto A; Kobayashi S; Sato A; Nagatake T
J Hosp Infect; 2001 Apr; 47(4):294-300. PubMed ID: 11289773
[TBL] [Abstract][Full Text] [Related]
12. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of methicillin resistant and mupirocin-resistant Staphylococcus aureus strains among medical students of Medical University in Warsaw.
Szymanek-Majchrzak K; Kosiński J; Żak K; Sułek K; Młynarczyk A; Młynarczyk G
Przegl Epidemiol; 2019; 73(1):39-48. PubMed ID: 31134773
[TBL] [Abstract][Full Text] [Related]
15. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
17. The persistence of Staphylococcus aureus decolonization after mupirocin and topical chlorhexidine: implications for patients requiring multiple or delayed procedures.
Immerman I; Ramos NL; Katz GM; Hutzler LH; Phillips MS; Bosco JA
J Arthroplasty; 2012 Jun; 27(6):870-6. PubMed ID: 22397861
[TBL] [Abstract][Full Text] [Related]
18. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?
Walker ES; Vasquez JE; Dula R; Bullock H; Sarubbi FA
Infect Control Hosp Epidemiol; 2003 May; 24(5):342-6. PubMed ID: 12785407
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
LaPlante KL
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
[TBL] [Abstract][Full Text] [Related]
20. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride.
Rohr U; Mueller C; Wilhelm M; Muhr G; Gatermann S
J Hosp Infect; 2003 Aug; 54(4):305-9. PubMed ID: 12919762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]